<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:TGTX (USA) Also Trade In: Germany UK

TG Therapeutics Inc $ 5.37 0.16 (3.07%)

Volume:
605,014
Avg Vol (1m):
1,062,160
Market Cap $:
508.83 Mil
Enterprise Value $:
461.71 Mil
P/E (TTM):
0.00
P/B:
35.34
Warning! GuruFocus has detected 4 Severe warning signs with TGTX. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

2/10
Current Vs Industry Vs History
Cash-To-Debt 2.25
Equity-to-Asset 0.12
Debt-to-Equity 2.87
Debt-to-EBITDA -0.24
N/A
Piotroski F-Score 2
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -9.17
DISTRESS
GREY
SAFE
Beneish M-Score -3.75
Not Manipulator
Manipulator
WACC vs ROIC
ROIC 0%
WACC 15.98%

Profitability

2/10
Current Vs Industry Vs History
Operating Margin % -104415.13
Net Margin % -104723.68
ROE % -346.62
ROA % -141.41
ROC (Joel Greenblatt) % -2794.8
3-Year Revenue Growth Rate -12.6
N/A
3-Year EBITDA Growth Rate -18.6
N/A
3-Year EPS without NRI Growth Rate -18.6
N/A

Ratios

Current Vs Industry Vs History
PB Ratio 35.34
EV-to-EBIT -2.91
N/A
EV-to-EBITDA -2.92
N/A
EV-to-Revenue 3037.48
Current Ratio 1.69
Quick Ratio 1.69

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -16.4

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 38.36
Earnings Yield (Greenblatt) % -34.35